116 related articles for article (PubMed ID: 22896833)
1. Equilibrium and release properties of aqueous dispersions of non-steroidal anti-inflammatory drugs complexed with polyelectrolyte eudragit e 100.
Quinteros DA; Allemandi DA; Manzo RH
Sci Pharm; 2012; 80(2):487-96. PubMed ID: 22896833
[TBL] [Abstract][Full Text] [Related]
2. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.
Quinteros DA; Rigo VR; Kairuz AF; Olivera ME; Manzo RH; Allemandi DA
Eur J Pharm Sci; 2008 Jan; 33(1):72-9. PubMed ID: 18060747
[TBL] [Abstract][Full Text] [Related]
3. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
[TBL] [Abstract][Full Text] [Related]
4. Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique.
Ho C; Hwang GC
Pharm Res; 1992 Feb; 9(2):206-10. PubMed ID: 1553343
[TBL] [Abstract][Full Text] [Related]
5. Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.
Quinteros DA; Tártara LI; Palma SD; Manzo RH; Allemandi DA
J Pharm Sci; 2014 Dec; 103(12):3859-3868. PubMed ID: 25294798
[TBL] [Abstract][Full Text] [Related]
6. Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine.
Guzmán ML; Manzo RH; Olivera ME
Mol Pharm; 2012 Sep; 9(9):2424-33. PubMed ID: 22808998
[TBL] [Abstract][Full Text] [Related]
7. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
Hessemer V; Schmitt K; Jacobi A
Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
[TBL] [Abstract][Full Text] [Related]
8. Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies.
Guzman ML; Soria EA; Laino C; Manzo RH; Olivera ME
Eur J Pharm Biopharm; 2016 Oct; 107():263-72. PubMed ID: 27418392
[TBL] [Abstract][Full Text] [Related]
9. Equilibrium and release properties of hyaluronic acid-drug complexes.
Battistini FD; Olivera ME; Manzo RH
Eur J Pharm Sci; 2013 Jul; 49(4):588-94. PubMed ID: 23659801
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
Asghar LF; Chandran S
Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin-containing interpolyelectrolyte complexes based on Eudragit
Moustafine RI; Sitenkov AY; Bukhovets AV; Nasibullin SF; Appeltans B; Kabanova TV; Khutoryanskiy VV; Van den Mooter G
Int J Pharm; 2017 May; 524(1-2):121-133. PubMed ID: 28366803
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Eudragit® E100 and anionic drugs: addition of anionic polyelectrolytes and their influence on drug release performance.
Quinteros DA; Manzo RH; Allemandi DA
J Pharm Sci; 2011 Nov; 100(11):4664-73. PubMed ID: 21647887
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
14. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
[TBL] [Abstract][Full Text] [Related]
15. Accelerated ketoprofen release from polymeric matrices: importance of the homogeneity/heterogeneity of excipient distribution.
Gue E; Willart JF; Muschert S; Danede F; Delcourt E; Descamps M; Siepmann J
Int J Pharm; 2013 Nov; 457(1):298-307. PubMed ID: 24076398
[TBL] [Abstract][Full Text] [Related]
16. In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets.
Deb TK; Ramireddy B; Moin A; Shivakumar HG
Int J Pharm Investig; 2015; 5(1):65-72. PubMed ID: 25599035
[TBL] [Abstract][Full Text] [Related]
17. Eudragit® RL as a stabilizer for supersaturation and a substrate for nanocrystal formation.
Dereymaker A; Cinghia G; Van den Mooter G
Eur J Pharm Biopharm; 2017 May; 114():250-262. PubMed ID: 28189622
[TBL] [Abstract][Full Text] [Related]
18. Formation of Drug-Participating Catanionic Aggregates for Extended Delivery of Non-Steroidal Anti-Inflammatory Drugs from Contact Lenses.
Torres-Luna C; Koolivand A; Fan X; Agrawal NR; Hu N; Zhu Y; Domszy R; Briber RM; Wang NS; Yang A
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31658626
[TBL] [Abstract][Full Text] [Related]
19. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
20. Eudragit RL-based film coatings: How to minimize sticking and adjust drug release using MAS.
Rongthong T; Sungthongjeen S; Siepmann F; Siepmann J; Pongjanyakul T
Eur J Pharm Biopharm; 2020 Mar; 148():126-133. PubMed ID: 31982576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
